228 related articles for article (PubMed ID: 36727400)
21. GATA2 and marrow failure.
Fabozzi F; Strocchio L; Mastronuzzi A; Merli P
Best Pract Res Clin Haematol; 2021 Jun; 34(2):101278. PubMed ID: 34404529
[TBL] [Abstract][Full Text] [Related]
22. A Nationwide Study of GATA2 Deficiency in Norway-the Majority of Patients Have Undergone Allo-HSCT.
Jørgensen SF; Buechner J; Myhre AE; Galteland E; Spetalen S; Kulseth MA; Sorte HS; Holla ØL; Lundman E; Alme C; Heier I; Flægstad T; Fløisand Y; Benneche A; Fevang B; Aukrust P; Stray-Pedersen A; Gedde-Dahl T; Nordøy I
J Clin Immunol; 2022 Feb; 42(2):404-420. PubMed ID: 34893945
[TBL] [Abstract][Full Text] [Related]
23. GATA2 Deficiency in Adult Life Is Characterized by Phenotypic Diversity and Delayed Diagnosis.
Shamriz O; Zahalka N; Simon AJ; Lev A; Barel O; Mor N; Tal Y; Segel MJ; Somech R; Yonath H; Toker O
Front Immunol; 2022; 13():886117. PubMed ID: 35603181
[TBL] [Abstract][Full Text] [Related]
24. Breaking the spatial constraint between neighboring zinc fingers: a new germline mutation in GATA2 deficiency syndrome.
Cavalcante de Andrade Silva M; Katsumura KR; Mehta C; Velloso EDRP; Bresnick EH; Godley LA
Leukemia; 2021 Jan; 35(1):264-268. PubMed ID: 32286542
[No Abstract] [Full Text] [Related]
25. Comparison of Outcomes of Myeloablative Allogeneic Stem Cell Transplantation for Pediatric Patients with Bone Marrow Failure, Myelodysplastic Syndrome and Acute Myeloid Leukemia with and without Germline GATA2 Mutations.
Hofmann I; Avagyan S; Stetson A; Guo D; Al-Sayegh H; London WB; Lehmann L
Biol Blood Marrow Transplant; 2020 Jun; 26(6):1124-1130. PubMed ID: 32088370
[TBL] [Abstract][Full Text] [Related]
26. Phenotypic heterogeneity associated with germline
Haddox CL; Carr RM; Abraham RS; Perez Botero J; Rodriguez V; Pardanani A; Patnaik MM
Leuk Lymphoma; 2019 Dec; 60(13):3282-3286. PubMed ID: 31246134
[No Abstract] [Full Text] [Related]
27. Single-nucleotide human disease mutation inactivates a blood-regenerative GATA2 enhancer.
Soukup AA; Zheng Y; Mehta C; Wu J; Liu P; Cao M; Hofmann I; Zhou Y; Zhang J; Johnson KD; Choi K; Keles S; Bresnick EH
J Clin Invest; 2019 Mar; 129(3):1180-1192. PubMed ID: 30620726
[TBL] [Abstract][Full Text] [Related]
28. GATA2 and secondary mutations in familial myelodysplastic syndromes and pediatric myeloid malignancies.
Wang X; Muramatsu H; Okuno Y; Sakaguchi H; Yoshida K; Kawashima N; Xu Y; Shiraishi Y; Chiba K; Tanaka H; Saito S; Nakazawa Y; Masunari T; Hirose T; Elmahdi S; Narita A; Doisaki S; Ismael O; Makishima H; Hama A; Miyano S; Takahashi Y; Ogawa S; Kojima S
Haematologica; 2015 Oct; 100(10):e398-401. PubMed ID: 26022708
[No Abstract] [Full Text] [Related]
29. [Predisposition and progression of myelodysplastic syndromes].
Makishima H
Rinsho Ketsueki; 2021; 62(4):278-288. PubMed ID: 33967153
[TBL] [Abstract][Full Text] [Related]
30. Prevalence, clinical characteristics, and prognosis of GATA2-related myelodysplastic syndromes in children and adolescents.
Wlodarski MW; Hirabayashi S; Pastor V; Starý J; Hasle H; Masetti R; Dworzak M; Schmugge M; van den Heuvel-Eibrink M; Ussowicz M; De Moerloose B; Catala A; Smith OP; Sedlacek P; Lankester AC; Zecca M; Bordon V; Matthes-Martin S; Abrahamsson J; Kühl JS; Sykora KW; Albert MH; Przychodzien B; Maciejewski JP; Schwarz S; Göhring G; Schlegelberger B; Cseh A; Noellke P; Yoshimi A; Locatelli F; Baumann I; Strahm B; Niemeyer CM;
Blood; 2016 Mar; 127(11):1387-97; quiz 1518. PubMed ID: 26702063
[TBL] [Abstract][Full Text] [Related]
31. Synonymous GATA2 mutations result in selective loss of mutated RNA and are common in patients with GATA2 deficiency.
Kozyra EJ; Pastor VB; Lefkopoulos S; Sahoo SS; Busch H; Voss RK; Erlacher M; Lebrecht D; Szvetnik EA; Hirabayashi S; Pasaulienė R; Pedace L; Tartaglia M; Klemann C; Metzger P; Boerries M; Catala A; Hasle H; de Haas V; Kállay K; Masetti R; De Moerloose B; Dworzak M; Schmugge M; Smith O; Starý J; Mejstrikova E; Ussowicz M; Morris E; Singh P; Collin M; Derecka M; Göhring G; Flotho C; Strahm B; Locatelli F; Niemeyer CM; Trompouki E; Wlodarski MW;
Leukemia; 2020 Oct; 34(10):2673-2687. PubMed ID: 32555368
[TBL] [Abstract][Full Text] [Related]
32. Inherited GATA2 Deficiency Is Dominant by Haploinsufficiency and Displays Incomplete Clinical Penetrance.
Oleaga-Quintas C; de Oliveira-Júnior EB; Rosain J; Rapaport F; Deswarte C; Guérin A; Sajjath SM; Zhou YJ; Marot S; Lozano C; Branco L; Fernández-Hidalgo N; Lew DB; Brunel AS; Thomas C; Launay E; Arias AA; Cuffel A; Monjo VC; Neehus AL; Marques L; Roynard M; Moncada-Vélez M; Gerçeker B; Colobran R; Vigué MG; Lopez-Herrera G; Berron-Ruiz L; Méndez NHS; O'Farrill Romanillos P; Le Voyer T; Puel A; Bellanné-Chantelot C; Ramirez KA; Lorenzo-Diaz L; Alejo NR; de Diego RP; Condino-Neto A; Mellouli F; Rodriguez-Gallego C; Witte T; Restrepo JF; Jobim M; Boisson-Dupuis S; Jeziorski E; Fieschi C; Vogt G; Donadieu J; Pasquet M; Vasconcelos J; Ardeniz FO; Martínez-Gallo M; Campos RA; Jobim LF; Martínez-Barricarte R; Liu K; Cobat A; Abel L; Casanova JL; Bustamante J
J Clin Immunol; 2021 Apr; 41(3):639-657. PubMed ID: 33417088
[TBL] [Abstract][Full Text] [Related]
33. Monozygotic twins with shared de novo GATA2 mutation but dissimilar phenotypes due to differential promoter methylation.
Kim N; Choi S; Kim SM; Lee AC; Im K; Park HS; Kim JA; Kim K; Kim I; Chang YH; Lee DS
Leuk Lymphoma; 2019 Apr; 60(4):1053-1061. PubMed ID: 30714451
[TBL] [Abstract][Full Text] [Related]
34. GATA2 deficiency in a patient with a somatic mutation of GATA2.
Liu Q; Ju X; Peng H
QJM; 2024 Feb; 117(1):66-68. PubMed ID: 37802913
[No Abstract] [Full Text] [Related]
35. Somatic mutational landscape of hereditary hematopoietic malignancies caused by germline variants in RUNX1, GATA2, and DDX41.
Homan CC; Drazer MW; Yu K; Lawrence DM; Feng J; Arriola-Martinez L; Pozsgai MJ; McNeely KE; Ha T; Venugopal P; Arts P; King-Smith SL; Cheah J; Armstrong M; Wang P; Bödör C; Cantor AB; Cazzola M; Degelman E; DiNardo CD; Duployez N; Favier R; Fröhling S; Rio-Machin A; Klco JM; Krämer A; Kurokawa M; Lee J; Malcovati L; Morgan NV; Natsoulis G; Owen C; Patel KP; Preudhomme C; Raslova H; Rienhoff H; Ripperger T; Schulte R; Tawana K; Velloso E; Yan B; Kim E; Sood R; Hsu AP; Holland SM; Phillips K; Poplawski NK; Babic M; Wei AH; Forsyth C; Mar Fan H; Lewis ID; Cooney J; Susman R; Fox LC; Blombery P; Singhal D; Hiwase D; Phipson B; Schreiber AW; Hahn CN; Scott HS; Liu P; Godley LA; Brown AL;
Blood Adv; 2023 Oct; 7(20):6092-6107. PubMed ID: 37406166
[TBL] [Abstract][Full Text] [Related]
36. Lineage skewing and genome instability underlie marrow failure in a zebrafish model of GATA2 deficiency.
Mahony CB; Copper L; Vrljicak P; Noyvert B; Constantinidou C; Browne S; Pan Y; Palles C; Ott S; Higgs MR; Monteiro R
Cell Rep; 2023 Jun; 42(6):112571. PubMed ID: 37256751
[TBL] [Abstract][Full Text] [Related]
37. A novel germline GATA2 frameshift mutation with a premature stop codon in a family with congenital sensory hearing loss and myelodysplastic syndrome.
Nakazawa H; Yamaguchi T; Sakai H; Maruyama M; Kawakami T; Kawakami F; Nishina S; Ishikawa M; Kosho T; Ishida F
Int J Hematol; 2021 Aug; 114(2):286-291. PubMed ID: 33759087
[TBL] [Abstract][Full Text] [Related]
38. Secondary leukemia in patients with germline transcription factor mutations (RUNX1, GATA2, CEBPA).
Brown AL; Hahn CN; Scott HS
Blood; 2020 Jul; 136(1):24-35. PubMed ID: 32430494
[TBL] [Abstract][Full Text] [Related]
39. Bone marrow pathologic abnormalities in familial platelet disorder with propensity for myeloid malignancy and germline RUNX1 mutation.
Kanagal-Shamanna R; Loghavi S; DiNardo CD; Medeiros LJ; Garcia-Manero G; Jabbour E; Routbort MJ; Luthra R; Bueso-Ramos CE; Khoury JD
Haematologica; 2017 Oct; 102(10):1661-1670. PubMed ID: 28659335
[TBL] [Abstract][Full Text] [Related]
40. Quantitative and qualitative impairments in GATA2 and myeloid neoplasms.
Shimizu R; Yamamoto M
IUBMB Life; 2020 Jan; 72(1):142-150. PubMed ID: 31675473
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
